Affinity Chromatography
Drug Discovery: Overview
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 14, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Tomonori Arai1, Masayoshi Uehata, Hiroyuki Akatsuka
1Discovery Screening Center, Mitsubishi Tanabe Pharma, Saitama 335-8505, Japan. arai.tomonori@me.mt-pharma.co.jp
A new quantitative size-exclusion chromatography/liquid chromatography/mass spectrometry (qSEC-LC/MS) method rapidly evaluates protein-compound interactions. This affinity-based technique shows promise for drug discovery, though K(d) determination requires further refinement.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: